UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000013727
Receipt number R000016028
Scientific Title Efficacy of Tolvaptan in acute heart failure patients with preserved left ventricular ejection fraction
Date of disclosure of the study information 2014/04/16
Last modified on 2018/04/19 09:22:16

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy of Tolvaptan in acute heart failure patients with preserved left ventricular ejection fraction

Acronym

Efficacy of Tolvaptan in acute heart failure patients with preserved left ventricular ejection fraction

Scientific Title

Efficacy of Tolvaptan in acute heart failure patients with preserved left ventricular ejection fraction

Scientific Title:Acronym

Efficacy of Tolvaptan in acute heart failure patients with preserved left ventricular ejection fraction

Region

Japan


Condition

Condition

acute decompensated heart failure

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To elucidate the efficacy of Tolvaptan in acute heart failure patients with preserved left ventricular ejection fraction using cardiac sympathetic nerve activity as an indicator

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

H/M MIBG uptake ratio on the delayed images,
Changes in washout rate of cardiac MIBG

Key secondary outcomes

1)blood biomarkers: vasopressin, three fractions of catecholamine, renin activity, aldosterone levels and serum osmolality
2)urinary biomarker: urinary albumin, urine beta2-microglobulin, urinary L-FABP and urine osmolality
3) Transthoracic echocardiography: LVEF, LVDd/Ds, E/e', LAD
4) Holter electrocardiogram: (TWA, HRV, HRT)
5) arrhythmia
6) cardiovascular event
7) acute kidney injury


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Conventional therapy group

Interventions/Control_2

Tolvaptan add-on therapy group

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >

Gender

Male and Female

Key inclusion criteria

1) Patients with left ventricular ejection fraction>=45%
2) Patients with at least one sign of congestion (edema, pulmonary congestion, pleural effusion, jugular venous distention, orthopnea)
3)Patients who received sufficient explanation, understood it and gave written consent based on their free will, before participating in this study

Key exclusion criteria

1) Patients with hypernatremia (Na>147mEq/L)
2) Patients who do not need diuretic therapy because of dehydration
3) Patients with cardiovascular shock
4) Patients with anuria or patients under hemodialysis
5) Patients with acute coronary syndrome
6) Patients with insensitivity to thirst or difficulty in water intake
7) Patients who need mechanical circulatory assist device (IABP・PCPS)
8) Patients with malignant tumor
9) Patients who need temporary pacing because of bradycardia
10) Patients who were judged inappropriate by the principal investigator

Target sample size

120


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Shunsuke Tamaki

Organization

Osaka General Medical Center

Division name

Department of Cardiology

Zip code


Address

3-1-56 Bandai-Higashi, Sumiyoshi-ku, Osaka

TEL

06-6692-1201

Email

kenkyusien@gh.opho.jp


Public contact

Name of contact person

1st name
Middle name
Last name Shunsuke Tamaki

Organization

Osaka General Medical Center

Division name

Department of Cardiology

Zip code


Address

3-1-56 Bandai-Higashi, Sumiyoshi-ku, Osaka

TEL

06-6692-1201

Homepage URL


Email

kenkyusien@gh.opho.jp


Sponsor or person

Institute

Osaka General Medical Center

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 04 Month 16 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2014 Year 02 Month 16 Day

Date of IRB


Anticipated trial start date

2014 Year 04 Month 01 Day

Last follow-up date

2017 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2014 Year 04 Month 16 Day

Last modified on

2018 Year 04 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016028


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name